Calidi Biotherapeutics, Inc. Common Stock (NY:CLDI)
0.6552
-0.0200
(-2.96%)
Official Closing Price
Updated: 8:00 PM EST, Nov 12, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 35,224 |
| Open | 0.6781 |
| Bid (Size) | 0.6100 (1,000) |
| Ask (Size) | 0.7650 (400) |
| Prev. Close | 0.6752 |
| Today's Range | 0.6401 - 0.7008 |
| 52wk Range | 0.6200 - 24.96 |
| Shares Outstanding | 2,584,184 |
| Dividend Yield | N/A |
Top News
More News
MIT Researchers Engineer Donor Immune Cells to Wipe Out Cancer Cells
November 10, 2026
Performance
52-Week Range
97.4% below 52-week high
0.6552
0.6252W Low
24.9652W High
1 Week
14.4% below 1-week high
0.641W Low
0.771W High
Calidi Biotherapeutics, Inc. Common Stock (CLDI) traded between $0.62 and $24.96 over the past 52 weeks and last traded at $0.66, 97.4% below its 52-week high. Over the past week it ranged between $0.64 and $0.77.
Past 12 Months
1W
-$0.04
1M
-$0.24
3M
-$0.88
6M
-$2.38
YTD
-$18.22
1Y
-$23.50
CLDI was -97.3% over the past year, -78.4% over six months, -96.5% year to date, -6.4% in the last week.
12 Months vs Market
CLDI
-97.3%
DIA
+8.2%
SPY
+10.8%
QQQ
+10.8%
IWM
+14.3%
Over the past 12 months CLDI returned -97.3% versus DIA (Dow) +8.2%, SPY (S&P 500) +10.8%, QQQ (Nasdaq 100) +10.8% and IWM (Russell 2000) +14.3%.
Volume & Liquidity
0.32× 3-mo avg
Today 35,224
3-mo avg 111.2K
1W
30.8K
1M
45.8K
3M
111.2K
6M
215.0K
YTD
193.3K
1Y
167.9K
CLDI most recently traded 35,224 shares against a 3-month average daily volume of 111.2K.
More News
Read More
New Immunotherapy Prolongs Survival of Lung Cancer Patients
October 28, 2026
Why Treating Cancer is So Complicated
September 24, 2026
Eliminating “Immune Fog” Shows Promise in Cancer Interception
October 13, 2026
Pancreatic Cancer Exploits Wound-Healing Mechanism to Evade Immune System
September 16, 2026
Systemic Challenges in US Health Care Push Cancer Patients to Fly to China
September 15, 2026
Boosting Thymus Health Could Improve Treatment Outcomes in Lung Cancer
September 02, 2026
Little-Known Immune Cells Bolster Anticancer Fight, Study Finds
August 14, 2026
Existing Immune Protein May Boost Immunotherapy Against Cancer
August 05, 2026
Top movers in Monday's after hours session ↗
July 20, 2026
Frequently Asked Questions
Is Calidi Biotherapeutics, Inc. Common Stock publicly traded?
Yes, Calidi Biotherapeutics, Inc. Common Stock is publicly traded.
What exchange does Calidi Biotherapeutics, Inc. Common Stock trade on?
Calidi Biotherapeutics, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Calidi Biotherapeutics, Inc. Common Stock?
The ticker symbol for Calidi Biotherapeutics, Inc. Common Stock is CLDI on the New York Stock Exchange
What is the current price of Calidi Biotherapeutics, Inc. Common Stock?
The current price of Calidi Biotherapeutics, Inc. Common Stock is 0.6552
When was Calidi Biotherapeutics, Inc. Common Stock last traded?
The last trade of Calidi Biotherapeutics, Inc. Common Stock was at 11/12/26 08:00 PM ET
What is the market capitalization of Calidi Biotherapeutics, Inc. Common Stock?
The market capitalization of Calidi Biotherapeutics, Inc. Common Stock is 1.69M
How many shares of Calidi Biotherapeutics, Inc. Common Stock are outstanding?
Calidi Biotherapeutics, Inc. Common Stock has 2M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.